News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Moleculin says preclinical Annamycin activates CD8+ T cells and shows antitumor activity in pancreatic tumors.
  • AACR-published data imply Annamycin could be tested beyond AML and soft-tissue sarcoma in pancreatic cancer.
  • Trade plan: buy Energy Transfer at $20.10, stop $18.50, target $24 over about 45 trading days.
  • Lifetime Brands trades below 1x price-to-book and at a single-digit P/E, presenting a value investment case.
  • HII hosted the National Commission at Ingalls Shipbuilding, showcasing 13 ships in construction and infrastructure upgrades.

Latest Articles

Natera Chairman's Strategic Share Disposition Amid Clinical Milestones

Natera Chairman's Strategic Share Disposition Amid Clinical Milestones

Natera, Inc. (NASDAQ:NTRA) reports a significant insider transaction involving Executive Chairman Matthew Rabinowitz, who sold 1,000 shares of common stock valued at $280,000 on July 6, 2026. The sale, executed through a pre-established Rule 10b5-1 trading plan adopted in December 2025, was facilitated via indirect holdings held by his spouse. This…

Tesco (TSCDF) — A Low-Volatility Entry into a UK Grocery Rebound

Tesco (TSCDF) — A Low-Volatility Entry into a UK Grocery Rebound

Tesco's OTC-listed shares are trading slightly below their short- and medium-term moving averages, with bullish MACD momentum and concentrated short activity that can accelerate upside in low-volume conditions. This trade idea outlines a mid-term long with defined entry, stop and target and a balanced view of the risks that could derail the setup.

Viant Technology CFO Larry Madden Executes Planned Stock Sales

Viant Technology CFO Larry Madden Executes Planned Stock Sales

Viant Technology Inc. (NASDAQ:DSP) Chief Financial Officer Larry Madden completed a series of stock sales totaling approximately $389,773 between July 6 and July 8, 2026. The transactions, executed under a pre-established 10b5-1 trading plan adopted in December 2025, involved the disposal of 30,519 Class A Common Stock shares. Despite the insider a…

CoreWeave Executive Divestment and Market Context

CoreWeave Executive Divestment and Market Context

CoreWeave Chief Development Officer Brannin McBee executed a significant divestment of company equity through established trusts, coinciding with broader analyst scrutiny of the firm's financial trajectory and competitive positioning in the AI cloud sector. The transaction highlights ongoing executive liquidity events while the company navigates ra…

Omada Health CFO Steven Cook Executes $325K Stock Sale Under 10b5-1 Plan

Omada Health CFO Steven Cook Executes $325K Stock Sale Under 10b5-1 Plan

Steven L. Cook, Chief Financial Officer of Omada Health, Inc. (NASDAQ:OMDA), reported the sale of company common stock totaling $325,394 on June 22, 2026. The transaction involved the disposition of 17,950 shares at a weighted average price of $18.1278 per share. These sales were executed in multiple trades, with prices ranging from $18.00 to $18.3…

CoreWeave Executive McBee Executes $16.97M Sale Under Pre-Arranged Plan

CoreWeave Executive McBee Executes $16.97M Sale Under Pre-Arranged Plan

Brannin McBee, CoreWeave's Chief Development Officer, executed a series of transactions involving the sale and conversion of Class A Common Stock totaling approximately $16.97 million on July 6, 2026. The sales were conducted under a Rule 10b5-1 trading plan established in March 2026, covering shares held directly and through family trusts. Concurr…

Omada Health CFO Executes Scheduled Stock Sales Amid Valuation Debates

Omada Health CFO Executes Scheduled Stock Sales Amid Valuation Debates

Omada Health CFO Steven Cook sold $814,341 in company stock through a pre-arranged 10b5-1 plan, with shares acquired at prices between $7.68 and $8.28. The sales occur as the stock trades near $23, following a 49% six-month surge and a Q1 2026 earnings beat. Analysts at Citizens raised the price target to $21, while the company's valuation remains …

Rocket Lab CEO Peter Beck Liquidates $286.4 Million in Shares

Rocket Lab CEO Peter Beck Liquidates $286.4 Million in Shares

Rocket Lab Corp (NASDAQ:RKLB) Chief Executive Officer Peter Beck executed a substantial divestment of company equity, offloading approximately $286.4 million worth of common stock over a three-day period in early July 2026. The transactions, processed through a pre-established Rule 10b5-1 trading plan managed by the Equatorial Trust, resulted in th…